Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 19 May 1995:
Vol. 268. no. 5213, p. 961
DOI: 10.1126/science.268.5213.961
Prev | Table of Contents | Next

Articles

Corrections and Clarifications

In the news article "FDA puts the brakes on xenotransplants" by Rachel Nowak (5 May, p. 630) the description of the response of Columbia Presbyterian Medical Center in New York City to one of its investigators' proposal to test baboon-to-human heart transplants was incorrect. In fact, Columbia convened one panel of outside experts to advise its internal committees on the risks of xenotransplantation, and has since retained two outside experts as consultants to Robert Michler, the principle investigator for the xenotransplant trials. The institution also recommended that a group of experts on emerging infections be convened to examine the risk of viral transmission associated with xenotransplantation (Letters, 21 Apr., p. 349).

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)